AtriCure
ATRC
102 hedge funds and large institutions have $362M invested in AtriCure in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 17 closing their positions.
24% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 34
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less funds holding
Funds holding: 113 → 102 (-11)
17% less capital invested
Capital invested by funds: $437M → $362M (-$74.5M)
53% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$18.5M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$11.1M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$3.23M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$2.91M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$16.1M |
| 2 |
CCI
Columbus Circle Investors
|
-$7.52M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$4.68M |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
-$4.48M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$4.14M |
ATRC Hedge Fund Activity: Q2 2016 in Review
102 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q2 2016, worth a combined $362M — down 17% from $437M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ATRC and 8 opened new positions — a net loss of 9 holders — while 34 trimmed existing stakes and 42 added.
The largest buyer was Fidelity Investments, adding an estimated $18.5M. The largest seller was Adage Capital Partners, cutting an estimated $16.1M.
- 102 institutional investors held AtriCure (ATRC) as of Q2 2016, down from 113 in Q1 2016.
- Funds reported $362M of AtriCure stock for Q2 2016, down 17% quarter-over-quarter.
- 8 funds opened new AtriCure positions in Q2 2016 and 17 closed out, a net change of -9 holders.
- The largest AtriCure buyer in Q2 2016 was Fidelity Investments, an estimated $18.5M added.
- The largest AtriCure seller in Q2 2016 was Adage Capital Partners, an estimated $16.1M sold.
Based on aggregated 13F filings for Q2 2016.